Merck & Co., Inc. (BIT:1MRKX)

ShockWave Medical Statistics

Total Valuation

Merck & Co. has a market cap or net worth of EUR 171.81 billion. The enterprise value is 194.81 billion.

Market Cap	171.81B
Enterprise Value	194.81B

Important Dates

The last earnings date was Tuesday, July 29, 2025.

Earnings Date	Jul 29, 2025
Ex-Dividend Date	Mar 14, 2025

Share Statistics

Current Share Class	2.50B
Shares Outstanding	n/a
Shares Change (YoY)	-0.77%
Shares Change (QoQ)	-0.71%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.49B

Valuation Ratios

The trailing PE ratio is 12.30 and the forward PE ratio is 8.76.

PE Ratio	12.30
Forward PE	8.76
PS Ratio	3.17
PB Ratio	4.11
P/TBV Ratio	16.53
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.87, with an EV/FCF ratio of 15.54.

EV / Earnings	13.94
EV / Sales	3.57
EV / EBITDA	7.87
EV / EBIT	9.45
EV / FCF	15.54

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.72.

Current Ratio	1.42
Quick Ratio	0.82
Debt / Equity	0.72
Debt / EBITDA	1.23
Debt / FCF	2.40
Interest Coverage	18.86

Financial Efficiency

Return on equity (ROE) is 35.42% and return on invested capital (ROIC) is 18.13%.

Return on Equity (ROE)	35.42%
Return on Assets (ROA)	13.07%
Return on Invested Capital (ROIC)	18.13%
Return on Capital Employed (ROCE)	26.30%
Revenue Per Employee	732,014
Profits Per Employee	188,780
Employee Count	75,000
Asset Turnover	0.55
Inventory Turnover	2.20

Taxes

In the past 12 months, Merck & Co. has paid 2.34 billion in taxes.

Income Tax	2.34B
Effective Tax Rate	14.32%

Stock Price Statistics

The stock price has decreased by -33.53% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-33.53%
50-Day Moving Average	69.67
200-Day Moving Average	81.40
Relative Strength Index (RSI)	47.56
Average Volume (20 Days)	200

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.76

Income Statement

In the last 12 months, Merck & Co. had revenue of EUR 54.17 billion and earned 13.97 billion in profits. Earnings per share was 5.52.

Revenue	54.17B
Gross Profit	41.93B
Operating Income	20.49B
Pretax Income	16.32B
Net Income	13.97B
EBITDA	24.30B
EBIT	20.49B
Earnings Per Share (EPS)	5.52

Balance Sheet

The company has 7.34 billion in cash and 30.14 billion in debt, giving a net cash position of -22.80 billion.

Cash & Cash Equivalents	7.34B
Total Debt	30.14B
Net Cash	-22.80B
Net Cash Per Share	n/a
Equity (Book Value)	41.77B
Book Value Per Share	16.67
Working Capital	9.39B

Cash Flow

In the last 12 months, operating cash flow was 15.78 billion and capital expenditures -3.25 billion, giving a free cash flow of 12.54 billion.

Operating Cash Flow	15.78B
Capital Expenditures	-3.25B
Free Cash Flow	12.54B
FCF Per Share	n/a

Margins

Gross margin is 77.41%, with operating and profit margins of 37.82% and 25.79%.

Gross Margin	77.41%
Operating Margin	37.82%
Pretax Margin	30.12%
Profit Margin	25.79%
EBITDA Margin	44.86%
EBIT Margin	37.82%
FCF Margin	23.14%

Dividends & Yields

This stock pays an annual dividend of 2.22, which amounts to a dividend yield of 3.20%.

Dividend Per Share	2.22
Dividend Yield	3.20%
Dividend Growth (YoY)	5.72%
Years of Dividend Growth	4
Payout Ratio	48.95%
Buyback Yield	0.77%
Shareholder Yield	3.97%
Earnings Yield	8.13%
FCF Yield	7.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.34 and a Piotroski F-Score of 6.

Altman Z-Score	4.34
Piotroski F-Score	6